101 related articles for article (PubMed ID: 26134925)
1. In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer.
Dubey P; Gidwani B; Pandey R; Shukla SS
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1491-7. PubMed ID: 26134925
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine.
Khan I; Gothwal A; Sharma AK; Qayum A; Singh SK; Gupta U
Int J Biol Macromol; 2016 Nov; 92():1242-1251. PubMed ID: 27527691
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
[TBL] [Abstract][Full Text] [Related]
4. Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.
Gidwani B; Vyas A
Pharm Dev Technol; 2016 Mar; 21(2):161-71. PubMed ID: 25391288
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
Han Y; Zhang P; Chen Y; Sun J; Kong F
Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
[TBL] [Abstract][Full Text] [Related]
6. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
[TBL] [Abstract][Full Text] [Related]
7. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
8. Box-Behnken Design of Experiment Assisted Development and Optimization of Bendamustine HCl loaded Hydroxyapatite Nanoparticles.
Thomas SC; Madaan T; Iqbal Z; Talegaonkar S
Curr Drug Deliv; 2018; 15(9):1230-1244. PubMed ID: 29929464
[TBL] [Abstract][Full Text] [Related]
9. Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted Therapy.
Chuang CH; Wu PC; Tsai TH; Fang YP; Tsai YH; Cheng TC; Huang CC; Huang MY; Chen FM; Hsieh YC; Lin WW; Tsai MJ; Cheng TL
J Biomed Nanotechnol; 2017 Feb; 13(2):192-03. PubMed ID: 29377649
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
11. Delivery of paeonol by nanoparticles enhances its in vitro and in vivo antitumor effects.
Chen C; Jia F; Hou Z; Ruan S; Lu Q
Int J Nanomedicine; 2017; 12():6605-6616. PubMed ID: 28924345
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimetastatic effects of pemetrexed-loaded targeted nanoparticles in B
Lu N; Li R; Liu Q; Hu B; Xu X; Ji C; Han X; Wang P; Liu B
Drug Deliv; 2016 Sep; 23(7):2566-2574. PubMed ID: 26000825
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer.
Chen LX; Ni XL; Zhang H; Wu M; Liu J; Xu S; Yang LL; Fu SZ; Wu J
Int J Nanomedicine; 2018; 13():2463-2476. PubMed ID: 29719394
[TBL] [Abstract][Full Text] [Related]
14. Self-Assembled Nanoparticles of Amphiphilic Twin Drug from Floxuridine and Bendamustine for Cancer Therapy.
Zhang T; Huang P; Shi L; Su Y; Zhou L; Zhu X; Yan D
Mol Pharm; 2015 Jul; 12(7):2328-36. PubMed ID: 25996874
[TBL] [Abstract][Full Text] [Related]
15. EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.
Patel AR; Chougule M; Singh M
Pharm Res; 2014 Oct; 31(10):2796-809. PubMed ID: 24867421
[TBL] [Abstract][Full Text] [Related]
16. Delivery of vinblastine-containing niosomes results in potent in vitro/in vivo cytotoxicity on tumor cells.
Amiri B; Ahmadvand H; Farhadi A; Najmafshar A; Chiani M; Norouzian D
Drug Dev Ind Pharm; 2018 Aug; 44(8):1371-1376. PubMed ID: 29532687
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled PLGA Nanoparticles for Effective Targeting of Bendamustine in Tumor Bearing Mice.
Khan I; Gothwal A; Kaul A; Mathur R; Mishra AK; Gupta U
Pharm Res; 2018 Aug; 35(11):200. PubMed ID: 30171428
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
19. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
20. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
